Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Phase 4

Recruiting

• Conditions: Osteoporosis
• Interventions: Device: Ibandronic acid, vitamin D

• Registration Number: NCT02156999
• Lead Sponsor: Shinshu University

Brief Summary

To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2014-06-01
• Study First Submitted QC: 2014-06-03
• Study First Posted: 2014-06-05
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-20
• Last Update Posted: 2021-09-21
• Primary Completion: 2022-10
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Osteoporosis

Read More

Exclusion Criteria

• Kidney, parathyroid, congenital bone metabolic disease

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Osteoporosis	Ibandronic acid, vitamin D	-

Primary Outcome Measures

Name	Time	Method
Changes of bone mineral density	every 4-6 months	To examine the changes of bone mineral density for the purpose of the effectiveness of the drug

Secondary Outcome Measures

Name	Time	Method
Improvement of bone turnover markers	Every 3-6 months	To examine the changes of bone turnover markers for the purpose of the effectiveness of the drug

Trial Locations

Locations (1)

Showa Inan General Hospital; 🇯🇵 Komagane, Nagano, Japan